Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.22 USD | +4.65% | +0.87% | +8.93% |
Apr. 18 | Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing | MT |
Apr. 10 | ALX Oncology Reports Positive Data From Ongoing Phase 1/2 Trial of Evorpacept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.93% | 819M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.19% | 22.2B | |
-16.53% | 21.23B | |
-8.49% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- ALXO Stock
- News ALX Oncology Holdings Inc.
- Cantor Fitzgerald Adjusts Price Target for ALX Oncology to $60 From $103, Maintains Overweight Rating